Lineage Cell Therapeutics to Present at Dawson James Securities 5th Annual Small Cap Growth Conference on October 29, 2019

On October 22, 2019 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, reported that Brandi L. Roberts, Chief Financial Officer, will be presenting at the Dawson James Securities 5th Annual Small Cap Growth Conference on October 29th, 2019 at 4:05pm Eastern Time at the Wyndham Grand Hotel in the Preserve Ballroom in Jupiter, Florida (Press release, Lineage Cell Therapeutics, OCT 22, 2019, View Source [SID1234542406]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Interested parties can access a live audio webcast on the Events and Presentations section of Lineage’s website and an archived presentation will be available for 30 days.